Market revenue in 2023 | USD 388.2 million |
Market revenue in 2030 | USD 900.6 million |
Growth rate | 12.8% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Other Ablation Technologies |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.54% in 2023. Horizon Databook has segmented the Europe tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for a significant share of the tumor ablation market. Growing initiatives & awareness campaigns on early disease diagnosis and its treatment, greater extent of public funding in Europe’s healthcare system, increasing incidence of cancers, and rising life expectancy have contributed to market growth.
According to WHO, Europe accounts for nearly a quarter of total cancer cases worldwide, with 3.7 million new patients every year. Among all types of cancers, stomach, lung, liver, breast, and colon cancers have caused the highest number of deaths every year.
Furthermore, benefits associated with minimally invasive tumor ablation procedures, such as lower risk, less cost of procedure & shorter recovery duration, high adoption of advanced technologies, increasing reimbursement for surgical procedures, and growing demand for minimally invasive procedures over traditional methods, are expected to drive the market during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe tumor ablation market , including forecasts for subscribers. This continent databook contains high-level insights into Europe tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account